BioNTech SE has announced an update regarding its share repurchase program, which allows the Company to purchase American Depositary Shares (ADSs) for an aggregate amount of up ability to $1.0 billion. The buyback period commences on June 8, 2026, and is scheduled to authorization to conduct the ability to conduct the buyback program through May authorization to conduct the ability to conduct the buyback program through May 6, 2027.
